BioCatalystWatch
BBIOWorkspace / BBIO / OverviewCompany library
BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. (BBIO)

Website

Price
Market cap
Next catalystNov 27, 2026BBP-418 · Regulatory decisionSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

FGFR1 × FGFR2 × FGFR3

Upcoming / outlook

  • Timing and evidence

BBP-418

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

FGFR1 × FGFR2 × FGFR3

Upcoming / outlook

  • Timing and evidence

BBP-418

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

calcium-sensing receptor (CaSR)

PreINDP1P2P3FilingApproved
BBP-418

Upcoming / outlook

BBP-418

Upcoming / outlook

BBP-418

Upcoming / outlook

BBP-418

PreINDP1P2P3FilingApproved
Upcoming / outlook

TTR

Partner / License out

SHP2

PreINDP1P2P3FilingApproved

SHP2

PreINDP1P2P3FilingApproved

SHP2

PreINDP1P2P3FilingApproved

Approved / commercial

TTR

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

TTR

PreINDP1P2P3FilingApproved

History / paused

FGFR1 × FGFR2 × FGFR3

TTR

KRAS G12C

KRAS

PreINDP1P2P3FilingApproved

pantothenate kinases

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

BBIO PR & News

PR & News

BBIO SEC archive